Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study - Université de Lorraine Access content directly
Journal Articles Alimentary Pharmacology & Therapeutics (Suppl) Year : 2018

Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study

Dates and versions

hal-01720723 , version 1 (01-03-2018)

Identifiers

Cite

W. Yacoub, N. Williet, L. Pouillon, T. Di-Bernado, M. de Carvalho Bittencourt, et al.. Early vedolizumab trough levels predict mucosal healing in inflammatory bowel disease: a multicentre prospective observational study. Alimentary Pharmacology & Therapeutics (Suppl), 2018, 47 (7), pp.906-912. ⟨10.1111/apt.14548⟩. ⟨hal-01720723⟩
44 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More